These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20124546)

  • 1. The role of FGF-23 in CKD-MBD and cardiovascular disease: friend or foe?
    Larsson TE
    Nephrol Dial Transplant; 2010 May; 25(5):1376-81. PubMed ID: 20124546
    [No Abstract]   [Full Text] [Related]  

  • 2. [FGF-23: a new player in CKD-MBD].
    Cozzolino M
    G Ital Nefrol; 2009; 26(3):292. PubMed ID: 19554521
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibroblast growth factor 23 and matrix-metalloproteinases in patients with chronic kidney disease: are they associated with cardiovascular disease?
    Peiskerová M; Kalousová M; Kratochvílová M; Dusilová-Sulková S; Uhrová J; Bandúr S; Malbohan IM; Zima T; Tesar V
    Kidney Blood Press Res; 2009; 32(4):276-83. PubMed ID: 19797911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial dysfunction links cardiovascular disease to pediatric chronic kidney disease: the role of nitric oxide deficiency.
    Tain YL
    Acta Paediatr Taiwan; 2007; 48(5):246-50. PubMed ID: 18254572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FGF23: a key player in mineral and bone disorder in CKD.
    Komaba H; Fukagawa M
    Nefrologia; 2009; 29(5):392-6. PubMed ID: 19820750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissue.
    Toussaint ND; Elder GJ; Kerr PG
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):221-33. PubMed ID: 18987295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease.
    Kendrick J; Chonchol MB
    Nat Clin Pract Nephrol; 2008 Dec; 4(12):672-81. PubMed ID: 18825155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone health in chronic kidney disease-mineral and bone disease.
    Gal-Moscovici A; Sprague SM
    Adv Chronic Kidney Dis; 2007 Jan; 14(1):27-36. PubMed ID: 17200041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. With or without the kidney: the role of FGF23 in CKD.
    Fukagawa M; Kazama JJ
    Nephrol Dial Transplant; 2005 Jul; 20(7):1295-8. PubMed ID: 15840677
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular biomarkers in CKD: pathophysiology and implications for clinical management of cardiac disease.
    Roberts MA; Hare DL; Ratnaike S; Ierino FL
    Am J Kidney Dis; 2006 Sep; 48(3):341-60. PubMed ID: 16931208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candidate risk factors for cardiovascular disease in CKD.
    De Santo NG; Cirillo M; Perna A; Iacono G; Capasso G
    Semin Nephrol; 2006 Jan; 26(1):1-2. PubMed ID: 16412816
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation.
    Chitalia N; Raja RB; Bhandara T; Agrawal P; Kaski JC; Jha V; Banerjee D
    J Nephrol; 2010; 23(1):77-84. PubMed ID: 20091490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study.
    Tsioufis C; Vezali E; Tsiachris D; Dimitriadis K; Taxiarchou E; Chatzis D; Thomopoulos C; Syrseloudis D; Stefanadi E; Mihas C; Katsi V; Papademetriou V; Stefanadis C
    J Hypertens; 2009 Apr; 27(4):744-52. PubMed ID: 19516174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular disease and chronic kidney disease: insights and an update.
    Best PJ; Reddan DN; Berger PB; Szczech LA; McCullough PA; Califf RM
    Am Heart J; 2004 Aug; 148(2):230-42. PubMed ID: 15308992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of the World Kidney Day campaign on the awareness of chronic kidney disease and the status of risk factors for cardiovascular disease and renal progression.
    Chin HJ; Ahn JM; Na KY; Chae DW; Lee TW; Heo NJ; Kim S
    Nephrol Dial Transplant; 2010 Feb; 25(2):413-9. PubMed ID: 19783595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for chronic kidney disease: which strategy?
    Hallan SI; Stevens P
    J Nephrol; 2010; 23(2):147-55. PubMed ID: 20155721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney function, electrocardiographic findings, and cardiovascular events among older adults.
    Kestenbaum B; Rudser KD; Shlipak MG; Fried LF; Newman AB; Katz R; Sarnak MJ; Seliger S; Stehman-Breen C; Prineas R; Siscovick DS
    Clin J Am Soc Nephrol; 2007 May; 2(3):501-8. PubMed ID: 17699457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease].
    Ravera M; Paoletti E
    Ital Heart J Suppl; 2004 Jun; 5(6):436-44. PubMed ID: 15471148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic kidney disease: a risk factor for cardiovascular disease.
    Wali RK; Henrich WL
    Cardiol Clin; 2005 Aug; 23(3):343-62. PubMed ID: 16084283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension and the kidney.
    Wiederkehr M; Toto R; Fenves AZ; Ram CV
    Semin Nephrol; 2005 Jul; 25(4):236-45. PubMed ID: 16202696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.